Tobacco industry leverages internal research to influence EU nicotine product regulation

Tobacco companies are utilizing proprietary research to frame vaping and nicotine pouches as harm-reduction alternatives to cigarettes. This strategy aims to stall restrictive EU legislation, though the validity of these health claims remains contested by independent public health experts.